{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:50:08Z","timestamp":1791363008812,"version":"4.3.1"},"reference-count":29,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2019,7,31]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The optimal timing for transplantation is unclear in patients with Eisenmenger syndrome (ES). We investigated post-transplantation survival and transplantation-specific morbidity after heart\u2013lung transplantation (HLTx) or lung transplantation (LTx) in a cohort of Nordic patients with ES to aid decision-making for scheduling transplantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective, descriptive, population-based study of patients with ES who underwent transplantation from 1985 to 2012.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 714 patients with ES in the Nordic region, 63 (9%) underwent transplantation. The median age at transplantation was 31.9 (IQR 21.1\u201342.3) years. Within 30 days after transplantation, seven patients (11%) died. The median survival was 12.0 (95% CI 7.6 to 16.4) years and the overall 1-year, 5-year, 10-year and 15-year survival rates were 84.1%, 69.7%, 55.8% and 40.6%, respectively. For patients alive 1\u2009year post-transplantation, the median conditional survival was 14.8 years (95%\u2009CI 8.0 to 21.8), with 5-year, 10-year and 15-year survival rates of 83.3%, 67.2% and 50.0%, respectively. There was no difference in median survival after HLTx (n=57) and LTx (n=6) (14.9 vs 10.6 years, p=0.718). Median cardiac allograft vasculopathy, bronchiolitis obliterans syndrome and dialysis\/kidney transplantation-free survival rates were 11.2 (95% CI 7.8 to 14.6), 6.9 (95% CI 2.6 to 11.1) and 11.2 (95% CI 8.8 to 13.7) years, respectively. The leading causes of death after the perioperative period were infection (36.7%), bronchiolitis obliterans syndrome (23.3%) and heart failure (13.3%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study shows that satisfactory post-transplantation survival, comparable with contemporary HTx and LTx data, without severe comorbidities such as cardiac allograft vasculopathy, bronchiolitis obliterans syndrome and dialysis, is achievable in patients with ES, with a conditional survival of nearly 15 years.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2019-315345","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T17:25:41Z","timestamp":1566408341000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Outcome after heart\u2013lung or lung transplantation in patients with Eisenmenger syndrome"],"prefix":"10.1136","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8238-4535","authenticated-orcid":false,"given":"Cristel S","family":"Hjortsh\u00f8j","sequence":"first","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gilljam","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Dellgren","sequence":"additional","affiliation":[{"name":"Transplant Institute, Sahlgrenska Academy, University of Gothenburg, Gothenburg, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku O","family":"Pentik\u00e4inen","sequence":"additional","affiliation":[{"name":"Department of Paediatric Cardiology, Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Department of Paediatric Cardiology, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette Schophuus","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maila","family":"Turanlahti","sequence":"additional","affiliation":[{"name":"Department of Paediatric Cardiology, Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Thil\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lund University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"2025100706445981000_106.2.127.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5099.755"},{"key":"2025100706445981000_106.2.127.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.630715"},{"key":"2025100706445981000_106.2.127.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq011"},{"key":"2025100706445981000_106.2.127.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2011.00561.x"},{"key":"2025100706445981000_106.2.127.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2005.09.006","article-title":"A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension","volume":"151","author":"Singh","year":"2006","journal-title":"Am Heart J"},{"key":"2025100706445981000_106.2.127.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.883876"},{"key":"2025100706445981000_106.2.127.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.08.014"},{"key":"2025100706445981000_106.2.127.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.08.004"},{"key":"2025100706445981000_106.2.127.9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The registry of the International Society for heart and lung transplantation: Thirty-third adult lung and heart-lung transplant Report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2025100706445981000_106.2.127.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.07.020"},{"key":"2025100706445981000_106.2.127.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-016-0713-1","article-title":"State of the art of combined heart-lung transplantation for advanced cardiac and pulmonary dysfunction","volume":"18","author":"Idrees","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"2025100706445981000_106.2.127.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.06.014"},{"key":"2025100706445981000_106.2.127.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl017"},{"key":"2025100706445981000_106.2.127.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023033"},{"key":"2025100706445981000_106.2.127.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv743"},{"key":"2025100706445981000_106.2.127.16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310979"},{"key":"2025100706445981000_106.2.127.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.592386"},{"key":"2025100706445981000_106.2.127.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq249"},{"key":"2025100706445981000_106.2.127.19","first-page":"67","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"2016","author":"Gali\u00e8","year":"2015","journal-title":"Eur Heart J"},{"key":"2025100706445981000_106.2.127.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(01)03099-5"},{"key":"2025100706445981000_106.2.127.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(01)00420-X"},{"key":"2025100706445981000_106.2.127.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(99)01082-6"},{"key":"2025100706445981000_106.2.127.23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-5223(19)36061-1","article-title":"Combined heart-lung transplantation for end-stage Eisenmenger\u2019s syndrome","volume":"91","author":"McGregor","year":"1986","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025100706445981000_106.2.127.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.07.022"},{"key":"2025100706445981000_106.2.127.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs160"},{"key":"2025100706445981000_106.2.127.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.08.003"},{"key":"2025100706445981000_106.2.127.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2013.08.007"},{"key":"2025100706445981000_106.2.127.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.10.019"},{"key":"2025100706445981000_106.2.127.29","unstructured":"Hjortsh\u00f8j CMS , Kempny A , Jensen AS , et al . Past and current cause-specific mortality in Eisenmenger syndrome. Eur Heart J."}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-315345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:58:27Z","timestamp":1759845507000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-315345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,12,24]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/heartjnl-2019-315345"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-315345","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]}}}